Cyclocytidine in breast cancer.
D003504:Ancitabine / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003561:Cytarabine / Q000031:analogs & derivatives*; D005260:Female; D006801:Humans
D003561:Cytarabine; D003504:Ancitabine